Armata Pharmaceuticals is led by Dr. Deborah L. Birx, who serves as the Chief Executive Officer of the clinical-stage biotechnology company. Appointed to helm the enterprise, Dr. Birx brings extensive medical, scientific, and executive leadership experience, having previously directed major federal health initiatives and scientific research programs. Under her direction, the company focuses on advancing innovative synthetic phage therapeutics and precision biologics designed to combat severe antibiotic-resistant bacterial infections, overseeing clinical pipeline development and corporate growth strategies from its operational headquarters.